The Emirates Drug Establishment (EDE) has issued a precautionary recall of Nin 160 FMB-NML blue medical face masks, Batch No. 20251015, over quality and contamination concerns.
DUBAI: The Emirates Drug Establishment (EDE) has ordered a precautionary recall of blue medical face masks following a quality complaint and inspections that identified foreign materials or signs of contamination in some units.
The recall, announced on October 12, 2026, affects a specific batch of three-layer medical masks distributed in the UAE. Authorities have instructed suppliers, healthcare facilities and consumers to stop using the affected products immediately.
Which medical face masks are affected?
The recall applies specifically to Nin 160 FMB-NML Facemask C G blue 3PLY, bearing Batch No. 20251015.
Consumers are advised to check the batch number printed on the product packaging to determine whether their masks are affected.
The Emirates Drug Establishment (EDE) confirmed that the recall followed a product quality complaint. Subsequent inspections detected foreign materials or signs of contamination in some masks from the affected batch.
The precautionary recall is limited to the identified batch and does not apply to all three-ply medical face masks available in the UAE.
What should consumers do?
Residents who have purchased the affected masks should check their packaging and compare the batch number with the recall notice.
Anyone possessing masks from Batch No. 20251015 has been advised to discontinue use and return the product to the original point of purchase or supplier.
Consumers should also report any product quality concerns or adverse incidents through the EDE’s approved reporting channels.
The authority has not announced that all blue medical face masks are unsafe. The warning concerns the specific product and batch identified in the recall.
What action must hospitals and pharmacies take?
The EDE has instructed healthcare providers, medical facilities and pharmaceutical establishments to immediately stop selling, supplying, distributing or using products from the affected batch.
Facilities must identify their remaining stock, isolate the affected units and return them to the local supplier.
Distributors have also been ordered to withdraw the affected products from the UAE market and prevent further circulation.
Additionally, they must provide comprehensive records covering the quantities imported, distributed, recalled and remaining in stock, together with distribution details.
The Dubai Health Authority reinforced the instructions through Circular No. 42/2026, directed at Dubai’s private healthcare sector.
Dubai Health Authority
Why was the recall necessary?
The recall was introduced as a precaution after inspections raised concerns about product quality.
Medical masks are intended to provide a protective barrier, making manufacturing quality and product integrity important considerations.
Removing the affected batch from circulation aims to prevent further use while the authorities address the identified concerns.
Impact to expect
The recall may prompt UAE hospitals, pharmacies and consumers to check medical mask supplies more carefully. It also reinforces the importance of product traceability, quality inspections and prompt reporting of potentially defective healthcare products.
Residents should verify batch numbers before using existing stock and follow official instructions regarding returns.
